CORRECTION
Correction: A multicenter, randomized controlled trial of individualized occupational therapy for patients with schizophrenia in Japan Takeshi Shimada, Manami Ohori, Yusuke Inagaki, Yuko Shimooka, Naoya Sugimura, Ikuyo Ishihara, Tomotaka Yoshida, Masayoshi Kobayashi
The following copyright and trademark right statement is missing from the Acknowledgments and Table 3 footnote: Use of the ©MMAS is protected by US copyright laws. Permission for use is required. A license agreement is available from Donald E. Morisky, 294 Lindura Court, Las Vegas, NV 89138–4632;
[email protected] [2–4]. Three citations are missing from S3 File. Please see the corrected S3 File below. There is an error in Table 2, as the number of participants and the descriptions of schizophrenia and schizoaffective disorder in the diagnostic item of Table 2 was reversed. Specifically, the numbers in rows 7 and 8 were swapped. Please see the corrected Table 2 here.
a1111111111 a1111111111 a1111111111 a1111111111 a1111111111
OPEN ACCESS Citation: Shimada T, Ohori M, Inagaki Y, Shimooka Y, Sugimura N, Ishihara I, et al. (2018) Correction: A multicenter, randomized controlled trial of individualized occupational therapy for patients with schizophrenia in Japan. PLoS ONE 13(10): e0205549. https://doi.org/10.1371/journal. pone.0205549 Published: October 9, 2018 Copyright: © 2018 Shimada et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
PLOS ONE | https://doi.org/10.1371/journal.pone.0205549 October 9, 2018
1/3
Table 2. Demographic characteristics and baseline assessments results by treatment group (GOT + IOT; GOT alone). Statistic
P
t = 1.109
.269
χ2 = 0.0294
.864
χ2 = 0.441
.507
(3.604)
t = 1.731
.087
(11.756)
t = 1.484
.140
(43.561)
t = 0.149
.882
11.647
(2.100)
t = 0.863
.390
(25.000)
20
(29.412)
χ2 = 0.334
.563
51
(75.000)
48
(70.588)
56
(82.353)
58
(85.294)
χ2 = 0.964
.810
• Married
7
(10.294)
4
(5.882)
• Separated or divorced
4
(5.882)
5
(7.353)
• Widowed
1
(1.471)
1
(1.471)
• Yes
28
(41.176)
30
(44.118)
χ2 = 0.120
.729
• No
40
(58.824)
38
(55.882)
Variable Age (years), mean (SD)
GOT + IOT (n = 68)
GOT alone (n = 68)
41.391
(11.038)
43.389
(9.973)
• Male
34
(50.000)
33
(48.529)
• Female
34
(50.000)
35
(51.471)
• Schizophrenia
54
(79.412)
57
(83.824)
• Schizoaffective disorder
14
(20.588)
11
(16.176)
22.019
(3.890)
23.300
3.688
(3.309)
5.944
Total length of hospital stays (months)a, mean (SD)
30.889
(43.068)
32.024
Education (year), mean (SD)
11.339
(1.958)
• Yes
17
• No
Sex, n (%)
Diagnosis, n (%)
Age of onset (years), mean (SD) Number of hospital stays (times), mean (SD)
Experience of employment, n (%)
Marital status, n (%) • Single
Experience with OT, n (%)
Length to OT from hospitalization (days)b, mean (SD)
12.613
(10.429)
9.574
(9.248)
t = 1.761
.081
Length of OT intervention (days)c, mean (SD)
69.935
(20.051)
73.441
(17.291)
t = 1.070
.287
Number of OT sessions (times), mean (SD)
32.710
(7.920)
34.824
(7.350)
t = 1.578
.117
• Baseline
714.226
(242.970)
662.029
(250.817)
t = 1.203
.231
• Post
656.145
(254.030)
644.706
(248.549)
t = 0.259
.796
• Withdrawal/social engagement
6.161
(2.327)
6.294
(2.023)
t = 0.348
.728
• Interpersonal communication
5.806
(1.836)
6.103
(1.846)
t = 0.917
.361
• Pro-social activities
14.613
(7.347)
16.471
(7.408)
t = 1.434
.154
• Recreation
18.968
(6.631)
20.309
(5.628)
t = 1.247
.215
• Independence-competence
21.516
(6.378)
20.235
(6.948)
t = 1.092
.277
• Independence-performance
17.516
(5.072)
16.368
(4.488)
t = 1.370
.173
Antipsychotic (mg/day)d, mean (SD)
Prehospital social functioninge, mean (SD)
• Employment/occupation • SFS-J total
1.581
(2.526)
1.882
(2.011)
t = 0.757
.451
85.242
(21.760)
88.515
(19.031)
t = 0.915
.362
a
The total length of hospital stay represented the total length of all previous hospital stays.
b
The length to OT from hospitalization represented the length from hospitalization to start of OT.
c
The length of OT intervention represented the length from baseline to post intervention assessment. d Chlorpromazine equivalent dose e
Prehospital social functioning was assessed with SFS-J
GOT: group occupational therapy; IOT: individual occupational therapy; SD: standard deviation. https://doi.org/10.1371/journal.pone.0205549.t001
PLOS ONE | https://doi.org/10.1371/journal.pone.0205549 October 9, 2018
2/3
Supporting information S3 File. Protocol in English. (DOCX)
References 1.
Shimada T, Ohori M, Inagaki Y, Shimooka Y, Sugimura N, Ishihara I, et al. (2018) A multicenter, randomized controlled trial of individualized occupational therapy for patients with schizophrenia in Japan. PLoS ONE 13(4): e0193869. https://doi.org/10.1371/journal.pone.0193869 PMID: 29621261
2.
Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens. 2008; 10(5): 348–354. https://doi.org/10.1111/j.1751-7176. 2008.07572.x
3.
Morisky DE, DiMatteo MR. Improving the measurement of self-reported medication nonadherence: Final response. J Clin Epidemio. 2011; 64 (3): 262–263. https://doi.org/10.1016/j.jclinepi.2010.09.010
4.
Berlowitz DR, Foy CG, Kazis LE, Bolin LP, Conroy MB, Fitzpatrick P, et al., for the SPRINT Research Group. Effect of intensive blood-pressure treatment on patient-reported outcomes. N Engl J Med. 2017; 377(8): 733–744. https://doi.org/10.1056/NEJMoa1611179 PMID: 28834483
PLOS ONE | https://doi.org/10.1371/journal.pone.0205549 October 9, 2018
3/3
